- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
ECS Botanics Reports Record-breaking Harvest in Latest Quarter
The report zeroes in on company achievements, such as its highest-ever harvest, the launch of its direct-to-consumer strategy and the completion of a propagation and genetics room.
![Stock chart over cannabis leaves.](https://investingnews.com/media-library/stock-chart-over-cannabis-leaves.jpg?id=53093007&width=1200&height=800&quality=80&coordinates=0%2C0%2C0%2C0)
Medicinal cannabis company ECS Botanics Holdings (ASX:ECS) published its latest quarterly report on Tuesday (July 30), detailing company achievements and strategic investments during the period.
The report highlights ECS' highest-ever harvest of 6.8 tonnes of biomass, up 62 percent year-on-year. The company attributes the increase mainly to outdoor production, and believes it will be able to compete better with cheaper imports.
A portion of the report also details the company’s progress in direct-to-consumer (B2C) sales, which began after ECS made a one year agreement with Elite Medical Solutions in May of this year.
The partnership offers automatic renewal options and guarantees a minimum annual order of AU$380,000, with anticipated growth. It will retail ECS’ soft gel capsules and oral liquids under ECS' military veteran’s brand, RAP.
The company expects to launch its AVANI rapid range of VESIsorb capsules by its first fiscal quarter of 2025.
"As a result of the B2C initiatives, the increase in exports and the addition product available for sale, we are anticipating strong revenue growth in the next quarter," ECS states in its press release.
The company also notes the recent completion of a propagation and genetics room, a space that will allow it to “provide sufficient clones for the expansion and breed genetics” best suited to ECS' growing conditions.
Nine new protective crop enclosures (PCE) have also been ordered to keep up with demand. ECS said these PCEs are expected to increase production of premium dried flower by over 200 percent once fully operational.
Finance-wise, ECS delivered revenue of AU$4.5 million for its fourth fiscal quarter of 2024. Compared to the year-ago period, the amount is slightly down from AU$4.8 million. The company explained that this is due to pricing pressure in the Australian market, while B2C sales and exports to Germany remain in the early stages of development. Still, the amount is a 12 percent increase from the prior quarter, when ECS' revenue came in at AU$4 million.
“Launching our B2C brand is a crucial step in capturing additional market share and increasing our revenue streams … Our investments in infrastructure, including the construction of new PCEs and the propagation and genetics room, ensure that we continue to provide the best possible product for patients,” said Managing Director Nan-Maree Schoerie.
"Our record production this quarter, culminating in 6.8 tonnes of untrimmed dried flower, showcases the strides ECS has made in enhancing our production and cultivation to the highest possible standard,” she continued. “These achievements are pivotal as we set up to meet surging demand in both local and export markets.”
Don’t forget to follow us @INN_Australia for real-time news updates!
Securities Disclosure: I, Gabrielle de la Cruz, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.
Gabbie graduated with a journalism degree from Colegio de San Juan de Letran - Manila and has produced articles on a variety of topics, such as infrastructure, business and technology. Her creative portfolio includes written work on architecture, art and design. Gabbie covers the Australian market for the Investing News Network, focusing on the mining sector. When not in front of her desk, she is out scanning through vinyl records, exploring the international coffee culture and fighting for queer rights
Learn about our editorial policies.